University of Bristol Enterprise Fund
VC Fund
London, United Kingdom
University of Bristol Enterprise Fund is a commercial organization that provides in private investors opportunities.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries University of Bristol Enterprise Fund invests in
BiotechnologyHealth CareAgTechSensorContent
Stages University of Bristol Enterprise Fund invests in
SeedSeries AFunding Round
Countries University of Bristol Enterprise Fund invests in
United Kingdom
Investment Focus
Industry
- Biotechnology 3 (43%)
- Health Care 2 (29%)
- AgTech 1 (14%)
- Sensor 1 (14%)
- Content 1 (14%)
Stage
- Seed 3 (43%)
- Series A 2 (29%)
- Funding Round 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Duel
|
The Duel Brand Advocacy Platform enables brands to mobilize and manage entire communities of social affiliates, content creators and micro-influencers to acquire customers and drive revenue at scale. It also measures the true ROI of advocacy and its impact on Social Commerce, in comparison to ads.Committed to working with brands that put peopleand the planet over profit, Duel is Bcorp Certified and breaks a brand’s reliance on digital advertising through its Social Affiliate and Brand Ambassador programs.Founded by world-record breaking adventurer and former brand ambassador, Paul Archer, and viral games developer, Panagiotis Tsarouchis, the Duel team is made up of psychologists, brand experts and community builders from companies including Amazon and Lululemon. The platform is used by brands such as Charlotte Tilbury, Monica Vinader, Mint Velvet, NEOM Organics, ELEMIS and more, with the team having consulted with hundreds of other brands. | $2.3M / Seed / Oct 27, 2020 | |
LettUs Grow
|
LettUs Grow brings affordable food growing to the modern city. Our patent-pending aeroponic technology delivers consistent, rapid yields for vertical farms. Simple, efficient & sustainable.Having demonstrated significant yield benefits from our core technology, we are building Europe's first commercial-scale aeroponic vertical farm inBristol.LettUs Grow are raising a seed round to grow our team, expand testing capabilities and begin exporting to a global market that is growing 27% year on year.LettUs Grow partners include: - Bethnal Green Ventures - Grow Bristol CIC - SETsquared Bristol - University of Bristol - IoT Boost UKFor more, see: www.lettusgrow.comOr please feel free to get in touch! | $3.1M / Seed / Jan 09, 2020 | |
|
LettUs Grow
|
LettUs Grow brings affordable food growing to the modern city. Our patent-pending aeroponic technology delivers consistent, rapid yields for vertical farms. Simple, efficient & sustainable.Having demonstrated significant yield benefits from our core technology, we are building Europe's first commercial-scale aeroponic vertical farm inBristol.LettUs Grow are raising a seed round to grow our team, expand testing capabilities and begin exporting to a global market that is growing 27% year on year.LettUs Grow partners include: - Bethnal Green Ventures - Grow Bristol CIC - SETsquared Bristol - University of Bristol - IoT Boost UKFor more, see: www.lettusgrow.comOr please feel free to get in touch! | Seed / Nov 18, 2019 | |
Industrial Phycology
|
Industrial Phycology has designed and patented a system to harness the power of algae to remove nutrients from the ground up using cutting edge methods and technologies, specifically for industrial scale use and to meet the needs of the wastewater operators for improved effluents. The benefits of such an approach are many and not limited. | $892K / Seed / Nov 05, 2019 | |
Mogrify
|
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via amulti-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type.The platforms can be used to enhance existing stem-cell forward programming methods, or bypass development pathways altogether, affecting a direct transdifferentiation between a mature cell type to another mature cell type.Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease.Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications. | $16M / Series A / Oct 14, 2019 | |
Inductosense
|
Inductosense is developing wireless, battery-free, sensors that can be permanently fixed to a product or structure for fast, repeatable inspections of cracks, defects or corrosion. The sensors can operate underneath coatings, insulation or repairs and can also be embedded into a material. They are entirely passive and the power and signal areprovided remotely by non-contact inductive coupling from a handheld measurement probe . The technology is referred to as the Wireless And Non Destructive (WAND) system. | $1.4M / Series A / Aug 23, 2017 | |
Micrima
|
Micrima Ltd. spun out from research at the University of Bristol. The Micrima team is developnig radio-wave technology for detecting breast cancer. The technology is non-invasive, non-ionising and inexpensive. The imaging technology has received extensive validation in the laboratory and is now undergoing first human use trials. | Sep 01, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
Health Care Investors
43,014 investors
Hardware Investors
40,144 investors
Media (entertainment) Investors
29,128 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Agriculture (agtech) Investors
10,346 investors
Health Care VC Funds
32,370 investors
Hardware VC Funds
30,945 investors
Media (entertainment) VC Funds
19,171 investors
FAQ
What does University of Bristol Enterprise Fund invest in?
University of Bristol Enterprise Fund invests primarily in Biotechnology, Health Care and AgTech startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did University of Bristol Enterprise Fund last invest?
The most recent investment recorded for University of Bristol Enterprise Fund closed in Oct 2020. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
